Literature DB >> 21997749

Diabetes: Safer PPARγ-targeted drugs on the horizon?

Sarah Crunkhorn.   

Abstract

Entities:  

Year:  2011        PMID： 21997749     DOI： 10.1038/nrd3587

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN： 1474-1776            Impact factor:   84.694


× No keyword cloud information.
  1 in total

1.  Antidiabetic actions of a non-agonist PPARγ ligand blocking Cdk5-mediated phosphorylation.

Authors:  Jang Hyun Choi; Alexander S Banks; Theodore M Kamenecka; Scott A Busby; Michael J Chalmers; Naresh Kumar; Dana S Kuruvilla; Youseung Shin; Yuanjun He; John B Bruning; David P Marciano; Michael D Cameron; Dina Laznik; Michael J Jurczak; Stephan C Schürer; Dušica Vidović; Gerald I Shulman; Bruce M Spiegelman; Patrick R Griffin
Journal:  Nature       Date:  2011-09-04       Impact factor: 49.962
  1 in total
  1 in total

Review 1.  Peroxisome proliferator activating receptor-γ and the podocyte.

Authors:  Caroline Platt; Richard J Coward
Journal:  Nephrol Dial Transplant       Date:  2017-03-01       Impact factor: 5.992
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.